Association between hemoglobin glycation index and all-cause mortality in patients with non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention - Report - MDSpire

Association between hemoglobin glycation index and all-cause mortality in patients with non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

  • By

  • Haodong Jiang

  • Yanlong Zhao

  • Yuanyuan Zhao

  • Shuai Wang

  • Wenliang Zhai

  • Zhi Liu

  • May 25, 2026

  • 0 min

Share

Clinical Report: Relationship Between Hemoglobin Glycation Index and Overall Mortality in NSTEMI Patients Undergoing Percutaneous Coronary Intervention

Overview

Revise to state that the study found an association between higher HGI and lower risk of mortality without implying causation.

Background

NSTEMI accounts for a significant portion of acute myocardial infarction cases and poses a considerable long-term mortality risk. Identifying reliable prognostic markers is crucial for improving risk stratification and management in this patient population. The hemoglobin glycation index (HGI) has emerged as a potential marker for cardiovascular risk, warranting further investigation.

Data Highlights

MeasureResult
1-unit increase in HGI43% lower risk of all-cause mortality (HR=0.57, 95% CI: 0.40–0.82, P=0.002)
Highest HGI tertile vs. lowest74% lower risk of mortality (HR=0.26, 95% CI: 0.10–0.66, P=0.004)

Key Findings

Remove phrases that imply interpretations or conclusions not directly stated in the source.

Clinical Implications

The findings suggest that HGI may serve as a complementary marker for risk stratification in NSTEMI patients undergoing PCI. Clinicians may consider incorporating HGI into their assessment protocols to better predict mortality risk in this population.

Conclusion

Rephrase to reflect findings without suggesting implications for clinical practice.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Frontiers in Cardiovascular Medicine — Impact of hypoglycemic regimens on cardiac recovery and quality of life after PCI in elderly AMI patients
  3. Frontiers in Cardiovascular Medicine — Effect of stress-induced hyperglycaemia on clinical outcome in paitients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
  4. Clinical Research in Cardiology — The Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Diabetic Patients Undergoing PCI for Non-ST-Segment Elevation Acute Coronary Syndromes: Influence of Clinical Condition and Procedural Factors
  5. Clinical Research in Cardiology — Impact of Glycoprotein IIb/IIIa Inhibitors on Hemorrhagic Complications Following Successful Resuscitation and Percutaneous Coronary Intervention
  6. ACC, AHA Issue New Acute Coronary Syndromes Guideline - American College of Cardiology
  7. Association of hemoglobin glycation index with clinical outcomes in patients with coronary artery disease: a prospective cohort study | Diabetology & Metabolic Syndrome | Full Text
  8. The association between the stress hyperglycaemia ratio and mortality in cardiovascular disease: a meta-analysis and systematic review | Cardiovascular Diabetology | Springer Nature Link

Original Source(s)

Association between hemoglobin glycation index and all-cause mortality in patients with non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

  • by Haodong Jiang, Yanlong Zhao, Yuanyuan Zhao, Shuai Wang, Wenliang Zhai, Zhi Liu

  • May 25, 2026

Related Content

Analysis of Risk Factors for Heart Failure in Patients with Type 2 Diabetes Mellitus and Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention

Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets

Management of Femoral Large-Bore Access and Closure During Microaxial Flow Pump-Supported Interventions